<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01036490</url>
  </required_header>
  <id_info>
    <org_study_id>F7264-R</org_study_id>
    <nct_id>NCT01036490</nct_id>
  </id_info>
  <brief_title>Exercise in Obese Diabetic Patients With Chronic Kidney Disease</brief_title>
  <acronym>EX-ODCKD</acronym>
  <official_title>Structured Exercise in Obese Diabetic Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with type 2 diabetes, obesity, and chronic kidney disease are generally physically
      inactive, have a high mortality rate, and may benefit from an exercise program. This study
      seeks to determine if a structured exercise program will benefit the heart (improved exercise
      tolerance, decreased blood pressure) and/or the kidney (decreased protein loss in urine and
      stabilization of kidney function) and lead to improvements in diabetes, body composition, and
      quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with type 2 diabetes, obesity, and chronic kidney disease (CKD) are generally
      physically inactive, have a high mortality rate, and may benefit from an exercise program.
      However, there have been no randomized controlled trials to determine the benefits of
      exercise training in this population. This study seeks to substantiate the hypothesis that
      increasing energy expenditure by exercise training in the obese diabetic patient with CKD
      will result in the following benefits:

        1. Renal benefits, including reduction in proteinuria and stabilization of glomerular
           filtration rate (GFR)

        2. Cardiovascular benefits, including decreased blood pressure, decreased heart rate, and
           increased exercise tolerance.

        3. Improved glucose control (lower glycated hemoglobin), lipid control (decreased
           cholesterol with improved atherogenic profile)

        4. Improved body composition (weight loss, increased lean body mass and decreased fat
           mass).

        5. Decreased inflammation (assessed by high-sensitivity C-reactive protein), endothelial
           dysfunction (assessed by flow-mediated dilatation), and oxidative stress (assessed by
           reduced glutathione).

        6. Increased health-related quality of life.

      In preparation for this proposal, the investigators performed a 24-week randomized controlled
      feasibility study comparing aerobic exercise plus optimal medical management to medical
      management alone in patients with type 2 diabetes, obesity (BMI &gt; 30 kg/m2), and stage 2-4
      CKD (eGFR 15-90 mL/min/1.73m2) with persistent proteinuria of &gt; 200 mg/g. Subjects randomized
      to exercise underwent thrice weekly aerobic training for 6 followed by 18 weeks of supervised
      home exercise. The primary outcome variable was change in proteinuria. Exercise training
      resulted in a significant improvement in exercise duration during stress testing which
      persisted until 24 weeks. This was accompanied by significant decreases in resting systolic
      blood pressure and 24-hour proteinuria at 24 weeks. No changes were seen in the control
      group. The investigators concluded that exercise training in obese diabetic patients with CKD
      is feasible and results in a demonstrable training effect (increased exercise duration and
      decreased resting blood pressure). Moreover, it may decrease proteinuria and thus have a
      renoprotective effect.

      The investigators now propose a larger-scale randomized controlled trial to determine the
      effects of exercise on renal functions, cardiovascular fitness, inflammation, and oxidative
      stress in diabetic patients with CKD. This will be a 52-week randomized study based on the
      investigators' pilot study design with some modifications. As opposed to the 6-week training
      period and 18-week home exercise period utilized in the pilot study, subjects randomized to
      exercise will undergo 12 weeks of intensive exercise training in the exercise laboratory
      followed by 40 weeks of supervised home exercise training (total duration of study 1 year).
      Moreover, due to recent recommendations that resistance training be incorporated into
      exercise training regimens in type 2 diabetic patients, the investigators will incorporate
      resistance (strength) training in this proposal. The primary outcome variable will be change
      in proteinuria at 12 and 52 weeks. Secondary outcome variables will be change in albuminuria
      and estimated glomerular filtration rate (eGFR) at 12 and 52 weeks. In addition, the
      investigators will measure blood pressure (BP), glycated hemoglobin, lipid profile,
      C-reactive protein (CRP) levels, body weight and composition, endothelial dysfunction (by
      flow-mediated dilatation), and Quality of Life (QoL) evaluations. The Index of Coexistent
      Diseases (ICED) to measure comorbidities to determine if comorbid conditions had any
      influence on the outcomes of the study. The Center for Epidemiologic Studies Depression Scale
      (CES-D) will also be used to determine the influence of depression (covariate) on study
      outcomes and adherence with the study objectives.

      This study will directly address the effects of a structured exercise program in a patient
      population at high risk for cardiovascular complications. The investigators will specifically
      address the novel idea that exercise will not only improve cardiovascular fitness but will
      also ameliorate the renal complications resulting from diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2010</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Proteinuria</measure>
    <time_frame>12 weeks minus baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Proteinuria</measure>
    <time_frame>52 weeks minus baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Albuminuria</measure>
    <time_frame>12 weeks minus baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Albuminuria</measure>
    <time_frame>52 weeks minus baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Estimated Glomerular Filtration Rate (eGFR)</measure>
    <time_frame>12 weeks minus baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Estimated Glomerular Filtration Rate (eGFR)</measure>
    <time_frame>52 weeks minus baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercise training for 12 weeks followed by home exercise for 40 weeks</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus

          -  CKD Stages 2-4

          -  BMI &gt; 30

          -  Persistent proteinuria (urine protein/creatinine &gt; 200 mg/g for &gt; 3 mo)

          -  On treatment with ACE inhibitor or ARB

          -  On treatment with aspirin

          -  On treatment with statin (if LDL &gt; 100)

        Exclusion Criteria:

          -  Symptomatic neuropathy/retinopathy

          -  Positive stress test due to coronary arterial disease

          -  Symptomatic cardiovascular disease

          -  Congestive heart failure (New York Heart Association Class III or IV)

          -  Chronic obstructive pulmonary disease (FEV1 &lt; 50% predicted and/or requires
             supplemental oxygen support during exercise)

          -  Complaints of angina during the stress test

          -  Cerebrovascular disease/cognitive impairment

          -  Renal transplant

          -  Inability to walk on the treadmill

          -  Any unforeseen illness or disability that would preclude exercise testing or training

          -  Participation in a formal exercise program within the previous 12 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Leehey</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edward Hines Jr. VA Hospital, Hines, IL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eileen G. Collins, PhD RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edward Hines Jr. VA Hospital, Hines, IL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Edward Hines Jr. VA Hospital, Hines, IL</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2009</study_first_submitted>
  <study_first_submitted_qc>December 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2009</study_first_posted>
  <results_first_submitted>March 24, 2016</results_first_submitted>
  <results_first_submitted_qc>March 24, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 27, 2016</results_first_posted>
  <last_update_submitted>December 6, 2017</last_update_submitted>
  <last_update_submitted_qc>December 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from the outpatient medical clinics of Hines VA Hospital over the three-year period between January 2011 and January 2014</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Exercise</title>
          <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Dietary management alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise</title>
          <description>12-week (3 days per week) program of aerobic and resistance training followed by 40 weeks of a home exercise program plus nutritional counseling</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Nutritional counseling alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="8.7"/>
                    <measurement group_id="B2" value="67" spread="7.5"/>
                    <measurement group_id="B3" value="66" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.2" spread="4.8"/>
                    <measurement group_id="B2" value="37.4" spread="4.2"/>
                    <measurement group_id="B3" value="37" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Proteinuria</title>
        <time_frame>12 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Proteinuria</title>
          <units>mg/g creatinine</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-34" lower_limit="-236" upper_limit="247"/>
                    <measurement group_id="O2" value="-133" lower_limit="-406" upper_limit="-75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Proteinuria</title>
        <time_frame>52 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Proteinuria</title>
          <units>mg/g creatinine</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="-433" upper_limit="428"/>
                    <measurement group_id="O2" value="-66" lower_limit="-729" upper_limit="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.39</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Albuminuria</title>
        <time_frame>12 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Albuminuria</title>
          <units>mg/g creatinine</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11" lower_limit="-148" upper_limit="203"/>
                    <measurement group_id="O2" value="-87" lower_limit="-323" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Albuminuria</title>
        <time_frame>52 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Albuminuria</title>
          <units>mg/g creatinine</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13" lower_limit="-372" upper_limit="233"/>
                    <measurement group_id="O2" value="-31" lower_limit="-598" upper_limit="238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Estimated Glomerular Filtration Rate (eGFR)</title>
        <time_frame>12 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Estimated Glomerular Filtration Rate (eGFR)</title>
          <units>mL/min/1.73m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="4.7"/>
                    <measurement group_id="O2" value="-3.4" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.15</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Estimated Glomerular Filtration Rate (eGFR)</title>
        <time_frame>52 weeks minus baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Dietary management alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Estimated Glomerular Filtration Rate (eGFR)</title>
          <units>mL/min/1.73m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="5.8"/>
                    <measurement group_id="O2" value="-3.1" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.58</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Exercise</title>
          <description>Dietary management plus 12 weeks of combined aerobic and resistance exercise training followed by 40 weeks of supervised home exercise.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Dietary management alone</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Due to inability to reach our expected target randomization (30 per group), our study may be underpowered to detect differences between the groups.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>David J. Leehey, M.D.</name_or_title>
      <organization>Hines VA Hospiral</organization>
      <phone>(708)2022589</phone>
      <email>david.leehey@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

